Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Medigus (MDGS) stocks in Canada

Learn how to easily invest in Medigus stocks.

Medigus is a medical devices business based in the US. Medigus stocks (MDGS.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.84 – a decrease of 11.11% over the previous week. Medigus employs 39 staff and has a trailing 12-month revenue of around $2.9 million.

How to buy shares in Medigus

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MDGS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Medigus stock price (NASDAQ:MDGS)

Use our graph to track the performance of MDGS stocks over time.

Medigus shares at a glance

Information last updated 2022-01-25.
Latest market close$0.88
52-week range$0.90 - $3.77
50-day moving average $1.13
200-day moving average $1.51
Wall St. target priceN/A
PE ratio 2.0457
Dividend yield N/A (0%)
Earnings per share (TTM) $0.48

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Medigus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Medigus price performance over time

Historical closes compared with the close of $0.88 from 2022-01-27

1 week (2022-01-21) -11.11%
1 month (2021-12-28) -12.87%
3 months (2021-10-28) -43.59%
6 months (2021-07-28) -46.01%
1 year (2021-01-28) -70.67%
2 years (2020-01-28) -51.38%
3 years (2019-01-28) 2.39
5 years (2017-01-27) 79.59%

Is Medigus under- or over-valued?

Valuing Medigus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medigus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Medigus's P/E ratio

Medigus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Medigus shares trade at around 2x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Medigus financials

Revenue TTM $2.9 million
Gross profit TTM $-503,000
Return on assets TTM -14.18%
Return on equity TTM 13.89%
Profit margin 281.06%
Book value $2.17
Market capitalisation $23.4 million

TTM: trailing 12 months

Medigus share dividends

We're not expecting Medigus to pay a dividend over the next 12 months.

Have Medigus's shares ever split?

Medigus's shares were split on a 1:4 basis on 15 July 2018. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Medigus shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Medigus shares which in turn could have impacted Medigus's share price.

Medigus share price volatility

Over the last 12 months, Medigus's shares have ranged in value from as little as $0.896 up to $3.77. A popular way to gauge a stock's volatility is its "beta".

MDGS.US volatility(beta: 2.08)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Medigus's is 2.077. This would suggest that Medigus's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Medigus overview

Medigus Ltd. , a medical device company, develops, produces, and markets minimally invasive endo-surgical tools with direct visualization technology in the United States, the United Kingdom, Europe, Asia, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; develops and commercializes online and offline event planning software, as well as ticketing solutions; and operates online stores for the sale of various consumer products on the Amazon online marketplace. The company was incorporated in 1999 and is headquartered in Omer, Israel. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site